Alterity Therapeutics Limited
ATH
Peringkat dalam Saham
#26110
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Harga Saham
$0.18265392
Kapitalisasi Pasar
$39.91M
Perubahan (1 hari)
1.96%
Perubahan (1 tahun)
-47.81%
Negara
AU
Perdagangan Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Riwayat harga saham Alterity Therapeutics Limited (ATH)
Harga penutupan tertinggi: $0.33 pada 2026-10-01
Harga penutupan terendah: $13.50 pada 2012-09-01
Harga penutupan terendah: $13.50 pada 2012-09-01
Riwayat harga saham Alterity Therapeutics Limited dari 2012 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | -12.13% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.63 | -3.92% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
